Literature DB >> 7592697

Chemokine class differences in binding to the Duffy antigen-erythrocyte chemokine receptor.

M C Szabo1, K S Soo, A Zlotnik, T J Schall.   

Abstract

The Duffy blood group antigen-erythrocyte chemokine receptor has been shown to bind to chemokines of both the C-X-C and C-C classes and to the malarial parasites Plasmodium vivax and Plasmodium knowlesi. We performed experiments to evaluate the binding properties of this receptor for the newly appreciated "C" and "non-ELR C-X-C" classes of chemokines. Binding to mouse erythrocytes was also evaluated for the first time. Whereas ELR C-X-C and C-C chemokines bound to human erythrocytes with high affinity, differences in the ability of non-ELR chemokines to act as competitive inhibitors were noted. While non-ELR chemokines were unable to displace C-X-C chemokines on human cells, they exhibited a low affinity interaction with the C-C chemokine binding site. The newly discovered C chemokine, lymphotactin, was unable to displace either C-X-C or C-C chemokines. On mouse erythrocytes, non-ELR chemokines exhibited a low affinity for both the C-X-C and C-C chemokines binding sites; again lymphotactin failed to bind. Binding competition studies using an anti-Duffy monoclonal antibody and chemokines suggested a common binding domain. These data show that the chemokine superfamily has at least four functional subdivisions, each interacting differently with the Duffy antigen-erythrocyte chemokine receptor. In addition the chemokine binding function is conserved between mouse and man. Unlike other proteins in the superfamily C and non-ELR C-X-C chemokines do not efficiently bind red blood cells, thus their role may not require clearance from circulation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7592697     DOI: 10.1074/jbc.270.43.25348

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  A recombinant dromedary antibody fragment (VHH or nanobody) directed against human Duffy antigen receptor for chemokines.

Authors:  Dorota Smolarek; Claude Hattab; Gholamreza Hassanzadeh-Ghassabeh; Sylvie Cochet; Carlos Gutiérrez; Alexandre G de Brevern; Rachanee Udomsangpetch; Julien Picot; Magdalena Grodecka; Kazimiera Wasniowska; Serge Muyldermans; Yves Colin; Caroline Le Van Kim; Marcin Czerwinski; Olivier Bertrand
Journal:  Cell Mol Life Sci       Date:  2010-05-11       Impact factor: 9.261

2.  The Duffy antigen modifies systemic and local tissue chemokine responses following lipopolysaccharide stimulation.

Authors:  Janet S Lee; Mark M Wurfel; Gustavo Matute-Bello; Charles W Frevert; Matthew R Rosengart; Mrunalini Ranganathan; Venus W Wong; Tarah Holden; Steve Sutlief; Ann Richmond; Stephen Peiper; Thomas R Martin
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

3.  Cloning, characterization, and mapping of a murine promiscuous chemokine receptor gene: homolog of the human Duffy gene.

Authors:  H Luo; A Chaudhuri; K R Johnson; K Neote; V Zbrzezna; Y He; A O Pogo
Journal:  Genome Res       Date:  1997-09       Impact factor: 9.043

Review 4.  In silico studies on DARC.

Authors:  Alexandre G de Brevern; Ludovic Autin; Yves Colin; Olivier Bertrand; Catherine Etchebest
Journal:  Infect Disord Drug Targets       Date:  2009-06

5.  Binding of RANTES, MCP-1, MCP-3, and MIP-1alpha to cells in human skin.

Authors:  E Hub; A Rot
Journal:  Am J Pathol       Date:  1998-03       Impact factor: 4.307

6.  The Duffy Antigen/Receptor for Chemokines (DARC) and prostate-cancer risk among Jamaican men.

Authors:  Joshua K Elson; Jennifer L Beebe-Dimmer; Hal Morgenstern; Mahdavi Chilkuri; John Blanchard; Alex B Lentsch
Journal:  J Immigr Minor Health       Date:  2011-02

7.  Atypical chemokine receptor 1 deficiency reduces atherogenesis in ApoE-knockout mice.

Authors:  Wuzhou Wan; Qian Liu; Michail S Lionakis; Ana Paula M P Marino; Stasia A Anderson; Muthulekha Swamydas; Philip M Murphy
Journal:  Cardiovasc Res       Date:  2015-04-08       Impact factor: 10.787

8.  Purification and biochemical characterization of the D6 chemokine receptor.

Authors:  Paul E Blackburn; Clare V Simpson; Robert J B Nibbs; Maureen O'Hara; Rhona Booth; Jemma Poulos; Neil W Isaacs; Gerard J Graham
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

9.  Duffy Blood Group System and the malaria adaptation process in humans.

Authors:  Gledson Barbosa de Carvalho; Glauber Barbosa de Carvalho
Journal:  Rev Bras Hematol Hemoter       Date:  2011

10.  Differential ligand binding to a human cytomegalovirus chemokine receptor determines cell type-specific motility.

Authors:  Jennifer Vomaske; Ryan M Melnychuk; Patricia P Smith; Joshua Powell; Laurel Hall; Victor DeFilippis; Klaus Früh; Martine Smit; David D Schlaepfer; Jay A Nelson; Daniel N Streblow
Journal:  PLoS Pathog       Date:  2009-02-20       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.